Product Name | MF | CAS | Details |
---|
FBXO24 Blocking Peptide | Details |
2-(2-Oxoimidazolidin-1-yl)acetic acid | C5H8N2O3 | 87219-22-5 | Details |
Phenylmalonic acid | C9H8O4 | 2613-89-0 | Details |
TROVE2 antibody | Details |
(4-Cyclopropyl-2-fluorophenyl)methanamine | C10H12FN | 1248106-66-2 | Details |
1-(1,2,4-Oxadiazol-5-yl)-2-phenylethan-1-amine, trifluoroacetic acid | 1955557-04-6 | Details |
Ficlatuzumab | 1174900-84-5 | Details |
(3-Chloro-phenyl)-acetic acid hydrazide | C8H9ClN2O | 66464-86-6 | Details |
Cucurbitacin I - Bio-X ? | C30H42O7 | 2222-07-3 | Details |
2'-Deoxy-L-guanosine | C10H13N5O4 | 22837-44-1 | Details |
Brain Natriuretic Peptide(BNP,Porcine,1-26) Antiserum | Details |
IgG (Fc) Goat Polyclonal Antibody | Details |
8-(3,5-Diethyl-1H-pyrazol-1-yl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione | C14H18N6O2 | 1014031-70-9 | Details |
3-(Acetamidomethyl)benzoic acid | C10H11NO3 | 777-69-5 | Details |
2-Methyl-1-(4-methylphenyl)propan-2-amine | C11H17N | 67510-95-6 | Details |
1-(1-Benzofuran-2-yl)-3-(morpholin-4-yl)propan-1-one hydrochloride | C15H18ClNO3 | 15817-89-7 | Details |
H-GDVAFVK-OH | Details |
4-[(Phenylamino)methyl]phenol hydrochloride | C13H14ClNO | 6337-84-4 | Details |
ABCC12 antibody | Details |
(R)-4-(2,4-Dimethoxybenzyl)-3-methylpiperazin-2-one | C14H20N2O3 | 1383146-20-0 | Details |
1-[(tert-Butoxy)carbonyl]-4,4-dimethylpiperidine-3-carboxylic acid | C13H23NO4 | 1798843-57-8 | Details |
1-(4-Nitro-benzenesulfonyl)-piperidine-4-carboxylic acid | C12H14N2O6S | 331828-49-0 | Details |
3'-O-Benzoylthymidine | C17H18N2O6 | 17331-53-2 | Details |
2'-O-Methyl-2-thiouridine | C10H14N2O5S | 113886-72-9 | Details |
RBL2 antibody | Details |
N-[(4-Methylmorpholin-2-yl)methyl]-1,3-thiazol-2-amine | C9H15N3OS | 1423035-13-5 | Details |
4-[(4-Chloro-1H-pyrazol-1-yl)methyl]-5-methylthiophene-2-carbaldehyde | C10H9ClN2OS | 1006448-83-4 | Details |
1-(2,4-Dichlorophenyl)-3-methyl-1H-pyrazol-5-amine | C10H9Cl2N3 | 81198-25-6 | Details |
Methyl 4-amino-1-ethyl-3-methyl-1H-pyrazole-5-carboxylate | C8H13N3O2 | 210163-95-4 | Details |
1-(2-Cyclopropyl-1,3-oxazol-4-yl)ethan-1-one | C8H9NO2 | 1519375-49-5 | Details |
H-WFSAGLASNSSWLR-OH | Details |
Hydromorphone-HRP | Details |
Valsartan - Bio-X ? | C24H29N5O3 | 137862-53-4 | Details |
ALDH4A1 antibody | Details |
6-Deoxy-6-thio-a-cyclodextrin | C36H60O24S6 | 180839-60-5 | Details |
Zoledronic acid monohydrate - Bio-X ? | C16H22ClN3 | 154-69-8 | Details |
Topotecan hydrochloride | C23H24ClN3O5 | 119413-54-6 | Details |
H-Arg-Arg-Lys-Asp-Leu-His-Asp-Asp-Glu-Glu-Asp-Glu-Ala-Met-Ser-Ile-Thr-Ala-OH | C85H139N27O35S | 154444-97-0 | Details |
Etonogestrel | C22H28O2 | 54048-10-1 | Details |
Etazolate hydrochloride | C14H18N5O2HCl | 35838-58-5 | Details |
3-[1-Butyl-5-(pyrrolidine-1-sulfonyl)-1H-1,3-benzodiazol-2-yl]propanoic acid | C18H25N3O4S | 790681-55-9 | Details |
4-chloro-2-nitro-N-(2-phenylethyl)benzene-1-sulfonamide | C14H13ClN2O4S | 1023875-76-4 | Details |
4-Cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine | C9H9N3 | 1318945-19-5 | Details |
C10ORF56 Blocking Peptide | Details |
α-N-Acetylglucosaminidase | 37288-40-7 | Details |
2-(2,6-dimethyl-3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H23BO3 | 1394909-88-6 | Details |
2,2,3,3,4,4-Hexafluorobutyric acid | C4H2F6O2 | 679-12-9 | Details |
rac-(1R,3S)-3-Aminocyclopentane-1-carbonitrile hydrochloride | C6H11ClN2 | 2216759-16-7 | Details |
N-(2-Aminoethyl)-N-methylthiophene-2-sulfonamide hydrochloride | C7H13ClN2O2S2 | 1423025-69-7 | Details |
Cis-mulberroside A | C26H32O14 | 166734-06-1 | Details |
T 82 | C30H33N3O6 | 252264-92-9 | Details |
Des[5-(2-dimethylamino)ethyl] diltiazem | C18H17NO4S | 87447-47-0 | Details |
5-Chloro-2-methylisonicotinic acid | C7H6ClNO2 | 1060810-03-8 | Details |
4'-Bromo-3'-(trifluoromethyl)acetophenone | C9H6BrF3O | 120077-70-5 | Details |
VPS26A Blocking Peptide | Details |
{1-Oxaspiro[4.4]nonan-2-yl}methanol | C9H16O2 | 129055-62-5 | Details |
MEA1 antibody | Details |
Icarisid II - Bio-X ? | C27 H30 O10 | 113558-15-9 | Details |
Edoxaban impurity G | C24H30ClN7O4S | 1255529-26-0 | Details |
2-Bromo-1-(1H-indol-3-yl)propan-1-one | C11H10BrNO | 19620-87-2 | Details |
1-Bromo-4-methoxycyclohexane | C7H13BrO | 1567059-60-2 | Details |
MRPL24 antibody | Details |
Iguratimod - Bio-X ? | C17H14N2O6S | 123663-49-0 | Details |
AZD 3988 | C23H22F2N4O4 | 892489-52-0 | Details |
Lidocaine antibody | Details |
1-[3-(Trifluoromethyl)phenyl]imidazolidin-2-one | C10H9F3N2O | 14088-95-0 | Details |
2,4-Anhydro-L-ribonic acid methyl ester | C6H10O5 | 1038922-16-5 | Details |
AN3485 hydrochloride | C14H14BCl2NO3 | 1213786-72-1 | Details |
Spiro[2.5]octan-6-one | C8H12O | 15811-21-9 | Details |
PQBP1 antibody | Details |
SLC6A15 Blocking Peptide | Details |
HER-2 substrate peptide | Details |
Pyrrolam A | C7H9NO | 113727-94-9 | Details |
(4-Bromo-1,3-oxazol-2-yl)methanol | C4H4BrNO2 | 1240615-29-5 | Details |
2-[2-(3-Amino-1H-pyrazol-1-yl)ethoxy]ethan-1-ol | C7H13N3O2 | 1248122-01-1 | Details |
N-{3-[(3-Bromopyridin-2-yl)amino]phenyl}acetamide | C13H12BrN3O | 1293156-74-7 | Details |
Methyl 5-(chlorosulfonyl)naphthalene-1-carboxylate | C12H9ClO4S | 141952-09-2 | Details |
H-SITSAVLQSGFRKMA-OH | Details |
2-(3-Amino-1H-pyrazol-1-yl)-6-fluorobenzonitrile | C10H7FN4 | 1249650-30-3 | Details |
ACCN5 antibody | Details |
Myosin 9 antibody (HRP) | Details |
2-Ethyl-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}pyrrolidine-2-carboxylic acid | C22H23NO4 | 1549438-52-9 | Details |
PRDX2 Blocking Peptide | Details |
2-[(Dimethylamino)methyl]cyclohexan-1-ol | C9H19NO | 17589-70-7 | Details |
3-(2,2-Difluoroethoxy)propanoic acid | C5H8F2O3 | 1545306-92-0 | Details |
rac-(2R,6R)-1-[(tert-Butoxy)carbonyl]-6-methylpiperidine-2-carboxylic acid | C12H21NO4 | 2166006-41-1 | Details |
HSV1 antibody (biotin) | Details |
Diphenyl-1,2-oxazol-5-amine | C15H12N2O | 52392-73-1 | Details |
5-Bromofuran-2-sulfonyl fluoride | C4H2BrFO3S | 2137682-74-5 | Details |
4-(4'-Benzamide)piperidine | C12H16N2O | 886362-49-8 | Details |
2,3-dimethyl-1-phenyl-4-((phenylsulfonyl)amino)-3-pyrazolin-5-one | C17H17N3O3S | 4392-43-2 | Details |
1-Isothiocyanato-4-(propan-2-yloxy)benzene | C10H11NOS | 50785-46-1 | Details |
2-[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]acetonitrile | C11H6Cl2N2S | 637015-80-6 | Details |
N-Acetyl-9-O-(N-acetyl-a-neuraminosyl)-neuraminic acid | C22H36N2O17 | 96425-77-3 | Details |
2-Methyl-5-(1-methyl-1H-imidazole-5-carbonyl)pyridine | C11H11N3O | 288392-21-2 | Details |
1-Bromo-3-(phenoxymethyl)benzene | C13H11BrO | 20600-29-7 | Details |
Ethyl 2,4-dihydroxy-6-methylnicotinate | C9H11NO4 | 10350-10-4 | Details |
tert-Butyl 4-(3-bromo-2-oxopropyl)piperidine-1-carboxylate | C13H22BrNO3 | 473795-43-6 | Details |
3-Cyclopropylcyclobutane-1-carboxylic acid | C8H12O2 | 1784150-06-6 | Details |
1-(((4-((5-chloro-2-methoxyphenyl)amino)(3,5-thiazolyl))methyl)sulfonyl)-4-methylbenzene | C18H17ClN2O3S2 | 1119392-32-3 | Details |
Product Total: Product Page: | ||||
28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 |